OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

Well here goes for me;
1. No RNS 20p by month end.
2. RNS too reach yr high of 39p min.
3. Multiple RNS it will rocket!
4. Hostile bid upwards of 50p, which would be a steal.
IMHO

Interesting

22/09/04 16:00 Holding(s) in Company RNS

Yes these folks are active in PRM as well, coincidence ?

On the up again!

18p now...on the up

Now UP 10.45%

There must be some news coming?

apple,

can you hazard a guess at what's driving this back up..??

regards

T..

img src="http://www.moneyam.com/cache/graph.php?size=Big&movingAverageString=%2C50%2C200&enableRSI=true&modeMA=Simple&movingAverageString1=&startDate=01%2F10%2F04&enableMA=true&period=2D&epic=%60UKX&periodRSI1=">

Tradx

Like I said there must be some news coming, I suppose that other people know before we do.

This company has so many drugs that there will be lots of news & any 1 of them could transform the company.

i suspect it is Trovax or Metxia

My guess is the treatment for MS - if so it will fly

Sorry - slip of the wine glass !!

UP 25% in 5 days :-)

apple,

thanks for the reply - I'm following the trend, the downside looks minimal, the upside - huge!

let's see what happens..

regards

T..

Times October 05, 2004

Smaller capitalisation shares
By Nick Hasell

Oxford BioMedica added 2p to 18p amid talk of an imminent bullish circular from Panmure Gordon, which the gene therapy specialist appointed as stockbroker in August.




--------------------------------
BTW
It seems that the overhang was cleared in September.

Neil Hume
Friday September 17, 2004
The Guardian
Oxford Biomedica jumped 1.75p to 17p as big overhang - 18m shares - was cleared.

Oxford Biomedica jumped 2p higher to 18.75p on rumours that the group is close to securing a major licensing deal for one of its products. The company has a large portfolio of drugs, including treatments for cancer and Parkinson's disease. Also boosting the shares yesterday was the clearance of a stock overhang, which had weighed on its performance for weeks.

http://tinyurl.com/7xaya

Thanks Janus

BTW the above from Janus came from
Michael Jivkov
TheIndependent
05 October 2004

Janus/apple - good posts thank you.

Looks like there is a 24 page brokers note released by Panmure Gordon. Gives a target price of 45 to 55p. I havent seen it any body confirm ?

Janus you are correct but note is for brokers and not general release. According to posters on ADVFN it reads extremely well and very well researched.